Joseph Douglas Lyon, Chief Accounting and Technology Officer, on May 27, 2026, sold 5,000 shares in Corcept Therapeutics (CORT) for $325,000. Following the Form 4 filing with the SEC, Lyon has control over a total of 6,230 common shares of the company, with 6,230 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000119312526248977/xslF345X05/ownership.xml